Patient-Specific Molecular Alterations Are Associated With Metastatic Clear Cell Renal Cell Cancer Progressing Under Tyrosine Kinase Inhibitor Therapy

Oncotarget - United States
doi 10.18632/oncotarget.18200
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Comparison of Tyrosine Kinase Inhibitor Versus Mammalian Target of Rapamycin Inhibitor as Second-Line Molecular-Targeted Therapy for Patients With Poor-Risk Metastatic Renal Cell Carcinoma

Anticancer Research
MedicineCancer ResearchOncology
2017English

Personalized Therapy in Renal Cell Carcinoma: Are the Different Tyrosine Kinase Inhibitors the Same for Any Patient?

Expert Review of Precision Medicine and Drug Development
Molecular MedicineDrug DiscoveryGeneticsPharmacology
2017English

Acanthosis Nigricans Associated With Clear-Cell Renal Cell Carcinoma

Autopsy and Case Reports
2016English

High Expression of FER Tyrosine Kinase Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma

Oncology Letters
Cancer ResearchOncology
2012English

Synchronous Metastatic Clear-Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype

Clinical Genitourinary Cancer
OncologyUrology
2017English

Molecular Genetics of Clear-Cell Renal Cell Carcinoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

Metastatic Renal Cell Cancer

Cancer Imaging
Nuclear MedicineRadiologyUltrasound TechnologyOncologyRadiologicalImagingMedicine
2013English

Systemic Therapy for Metastatic Non–Clear-Cell Renal Cell Carcinoma: Recent Progress and Future Directions

Hematology/Oncology Clinics of North America
OncologyHematology
2011English

IKBKB Expression in Clear Cell Renal Cell Carcinoma Is Associated With Tumor Grade and Patient Outcomes

Oncology Reports
MedicineCancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy